VanEck Vectors Biotech ETF News

Sector ETF report for BBH

Sector ETF report for BBH

Biotechnology stocks and the related exchange traded funds are in a prolonged slump, and along the way, calls for rebounds have been plentiful. They've also proven inaccurate.

Biotechnology stocks and exchange traded funds are into a second year of disappointing investors, but that condition won't be permanent. With that in mind, investors evaluating ideas for a biotech res

Biotechnology stocks and the related exchange traded funds are under pressure as growth stocks stumble this year, but interested investors have some potential positive facts to ponder. First, biotech

Since last year, biotechnology stocks and exchange traded funds have been among the most disappointing equity assets, wilting against the backdrop of the coronavirus pandemic and in advance of broader

Sector ETF report for BBH

Sector ETF report for BBH

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

BBH's price multiples indicate an undervaluation and its major holdings have started recording significant price growth. BBH has strong fundamentals and has performed well enough in the medium and lon

Biotechnology stocks and exchange traded funds have frustrated investors for over a year now, but some analysts and experts believe that this gloomy trend will end soon. Investors willing to take that

Moderna has been rallying on the latest positive booster shot-related update.

In financial markets, it's often said that cash is king. That's something to remember when it comes to the biotechnology universe due to the cost-intensive nature of developing new drugs and therapies

Sector ETF report for BBH